Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Operating expenses    
Research and development $ 25,000 $ 92,100
General and administrative 1,226,361 1,288,053
Total operating expenses 1,251,361 1,380,153
Operating loss (1,251,361) (1,380,153)
Interest expense 3,100  
Other expense (income)    
Change in fair value of warrant liability (1,162,493) (12,561)
Fair value of warrant liability in excess of proceeds 7,174,634  
Change in fair value of conversion rights of Series B preferred stock   (85,205)
Change in fair value of conversion rights of convertible debt 185,000  
Financing transaction costs 137,191  
Loss on extinguishment of convertible debt 590,392  
Amortization of convertible debt discount 34,608  
Net Loss before income taxes (8,213,793) (1,282,387)
Provision for income taxes   831
Net loss (8,213,793) (1,283,218)
Less: Preferred deemed dividend   711,000
Net loss applicable to common shareholders $ (8,213,793) $ (1,994,218)
Basic earnings per common share (in dollars per share) $ (0.09) $ (0.09)
Diluted earnings per common share (in dollars per share) $ (0.09) $ (0.09)
Weighted average shares of common stock outstanding    
Basic (in shares) 88,632,979 23,247,530
Diluted (in shares) 88,632,979 23,247,530